Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
08/2005
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176786 Anticancer agents; inhibit Abelson tyrosine kinase, Ron receptor tyrosine kinase, Met receptor tyrosine kinase, Fms-like tyrosine kinase-3, or p21-activated kinase-4; e.g. 3-substituted-5-(carbonylamino or sulfonamido)-1H-pyrazolo[3,4-d]thiazole
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176703 Heterocyclic antiviral compounds
08/11/2005US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
08/11/2005US20050175660 Stents, catheters,by-pass graft; drug delivery; balloon overcoated with drugs
08/11/2005CA2457459A1 Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
08/10/2005EP1560893A1 Photochromic compositions and light transmissible articles
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1395570B1 Oxazin(thi)one compounds used as fungicides
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653071A 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
08/10/2005CN1214087C Novel red fluorescent material and organic electroluminescent device containing same
08/10/2005CN1214009C antibacterial composition
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005CA2095659C Heteroatoms-containing tricyclic compounds
08/04/2005WO2005070941A1 Rifamycin imino derivatives effective against drug-resistant microbes
08/04/2005WO2005070940A2 Rifamycin derivatives effective against drug-resistant microbes
08/04/2005WO2005070938A1 Stable salts of olanzapine
08/04/2005WO2005070906A1 Organic compounds
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005069865A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
08/04/2005WO2005049735A3 A process for aqueous milling of quinacridone pigments
08/04/2005US20050171142 New crystalline monohydrates and crystalline anhydrates of gaboxadol; suitable for oral dosage administration
08/04/2005US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171100 Dehydrative cyclization of a 3,7-dihydroxy-1,5-diazacyclooctane compounds; one pot process with milder reaction conditions
08/04/2005US20050171087 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
08/04/2005US20050169993 Sustained-release formulation
08/04/2005US20050167637 cycloquaterbenzoxazoles, cycloquaternaphthoxazoles, cycloquaterbenzimidazoles and cycloquaternaphthimidazoles, used in photoactive performance chemicals, such as charge generating compounds in organic light emitter diodes,as phase transfer catalysts, dispersants in pigments or optical recording media
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553009A1 Organic compounds
08/03/2005EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias
08/03/2005EP1558622A1 Method of purifying macrolides
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005CN1649879A Non-steroidal progesterone receptor modulators
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649852A Method for extracting a macrolide from biomatter
08/03/2005CN1649551A Drug-delivery endovascular stent and method for treating restenosis
08/03/2005CN1213036C Novel amide derivatives
08/02/2005US6924280 Dipeptide derivatives
08/02/2005CA2321639C Bicyclo[2.2.1]heptanes and related compounds
07/2005
07/28/2005WO2005068473A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
07/28/2005WO2005068472A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases
07/28/2005WO2005068466A1 Compounds useful in therapy
07/28/2005WO2005067546A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
07/28/2005US20050165227 Antiproliferative agents; gene overexpression
07/28/2005US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide
07/28/2005US20050165045 Compounds and methods
07/28/2005US20050165029 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
07/28/2005US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
07/28/2005US20050164886 Herbicidal compositions
07/28/2005CA2554382A1 Compounds useful in therapy
07/28/2005CA2553202A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases
07/28/2005CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
07/27/2005EP1557421A1 Polymorphous forms of rifaximin as antibiotics
07/27/2005EP1557420A1 Process for producing optically active sulfoxide
07/27/2005EP1557418A1 Novel quinoxaline derivatives
07/27/2005EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics
07/27/2005EP1557410A2 Bacterial gyrase inhibitors and uses thereof
07/27/2005EP1557168A2 Biarylurea Derivatives
07/27/2005EP1343766B1 Cyclization process step in the making of quinolones and naphthyridines
07/27/2005CN1646537A Phosphorus-containing compounds & uses thereof
07/27/2005CN1646502A Triazole derivatives as tachykinin receptor antagonists
07/27/2005CN1646489A Delta1-pyrrolines and their use as pestcidal
07/27/2005CN1212323C Process for synthesizing oxazole [4,5-b] pyridine-2-(3H) ketone
07/27/2005CN1212317C Novel ester or amide derivatives
07/26/2005US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis
07/26/2005US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives
07/21/2005WO2005065779A1 Calcitonin gene related peptide receptor antagonists
07/21/2005US20050159602 Method for synthesizing chiral bicyclic thiazolidine hydantoin
07/21/2005US20050159596 Cyclic compounds and their use as complex ligands
07/21/2005US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
07/21/2005US20050159436 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
07/21/2005US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea
07/21/2005US20050159411 Bactericides for infrections in man
07/21/2005US20050159408 Heating a reaction mixture of N-methylpiperazine and thienobenzodiazepine to 110 to 145 degrees C
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/20/2005EP1555267A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES
07/20/2005EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
07/20/2005EP1554285A1 Chemical intermediate
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
07/20/2005EP1385852B1 Compounds and methods for inhibiting mrp1
07/20/2005EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
07/20/2005CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants
07/20/2005CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
07/20/2005CN1642924A Anxiolytic agents with reduced sedative and ataxic effects
07/20/2005CN1642917A Non-peptide GnRH antagonists
07/20/2005CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
07/20/2005CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them
07/20/2005CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
07/19/2005US6919450 Process for the preparation of benazepril
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919362 For use as hypoglycaemic and hypolipidaemic agents
07/19/2005US6919355 Amide derivatives as NMDA receptor antagonists
07/19/2005US6919334 Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
07/19/2005US6918958 Acid pigment dispersants and pigment preparations